Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01753895 · ClinicalTrials.gov registry record
Mercury Versus Automated Blood Pressure Monitoring
A clinical trial, sponsored by Rockefeller University.
- Completed
- Registry status
- 156
- Enrollment target
NCT01753895 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 156 participants.
The verdict
NCT01753895 has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 156 participants
- Enrollment target
Study Summary
Blood pressure (BP) measurement is one of the most commonly performed screening tests in the clinical setting. Its accuracy is vital to the early diagnosis and effective management of hypertension, as emphasized by hypertension management guidelines. For most protocols being conducted in a clinical research setting, obtaining single or serial blood pressure reading(s) is often performed as a safety assessment, especially if the individual is participating in a study that requires a blood draw and/or the administration of a research drug, vaccine or device. It is imperative that the blood pressure data truly reflect the response, if any, the study participant experiences in relation to the research procedures and interventions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01753895
The ClinicalTrials.gov registry entry for NCT01753895 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01753895 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01753895 about?
NCT01753895 is a clinical study titled "Mercury Versus Automated Blood Pressure Monitoring". Blood pressure (BP) measurement is one of the most commonly performed screening tests in the clinical setting. Its accuracy is vital to the early diagnosis and effective management of hypertension, as emphasized by hypertension management guidelines. For most protocols being conducted in a clinical ...
What is the current status of trial NCT01753895?
This trial is currently completed. The enrollment target is 156 participants. The study started on 2012-12. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT01753895?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.